Altimmune to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Altimmune (Nasdaq: ALT) said management will attend four investor conferences March 9–12, 2026, offering one-on-one meetings and several fireside chats.

Webcasts of fireside chats at Leerink, Citizens and Barclays will be available via the company Events page; registered investors may request meetings through bank sales contacts.

News Market Reaction – ALT

-3.48%

1 alert

-3.48% News Effect

On the day this news was published, ALT declined 3.48%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate and be available for one-on-one meetings at the following investor conferences:

• Leerink Global Healthcare Conference
  Monday, March 9, 2026 – One-on-one meetings
  Wednesday, March 11, 2026 – Fireside chat at 9:20 a.m. ET

• Citizens Life Sciences Conference
  Tuesday, March 10, 2026 – One-on-one meetings
  Fireside chat at 2:15 p.m. ET

• Jefferies Biotech on the Beach Summit
  Wednesday, March 11, 2026 – One-on-one meetings only

• Barclays 28^th Annual Global Healthcare Conference
  Thursday, March 12, 2026 – One-on-one meetings
  Fireside chat at 10:30 a.m. ET

Webcasts of the fireside chats at the Leerink, Citizens and Barclays conferences will be available via the Events section of the Altimmune website.

Registered investors may request meetings on the dates noted above via their sales contacts at the respective banks.

About Altimmune
Altimmune is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company’s lead candidate, pemvidutide, is a unique dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on X

Investor Contact:
Lee Roth
Burns McClellan
lroth@burnsmc.com

Media Contact:
Real Chemistry
altimmune@realchemistry.com

This press release was published by a CLEAR® Verified individual.

FAQ

When will Altimmune (ALT) management appear at investor conferences in March 2026?

Altimmune management will attend conferences March 9–12, 2026 with meetings and chats scheduled each day. According to the company, dates include Leerink on March 9–11, Citizens on March 10, Jefferies on March 11 and Barclays on March 12.

Which Altimmune (ALT) events will be webcast and where can investors watch?

Webcasts will be available for selected fireside chats at Leerink, Citizens and Barclays. According to the company, viewers can access those webcasts via the Events section of the Altimmune website for live or archived viewing.

How can registered investors request one-on-one meetings with Altimmune (ALT) at the March 2026 conferences?

Registered investors may request one-on-one meetings via their sales contacts at the respective banks hosting each conference. According to the company, meeting requests should be coordinated through the banks’ sales teams ahead of the conference dates.

What times are Altimmune (ALT) fireside chats scheduled during the March 2026 conferences?

Fireside chats are scheduled at specified times: March 11 at 9:20 a.m. ET (Leerink), March 10 at 2:15 p.m. ET (Citizens), and March 12 at 10:30 a.m. ET (Barclays). According to the company, these sessions are open via webcast.

Will Altimmune (ALT) present at Jefferies Biotech on the Beach on March 11, 2026?

Yes, Altimmune management will attend Jefferies Biotech on the Beach on March 11, 2026 offering one-on-one meetings only. According to the company, there is no fireside chat planned at the Jefferies event for Altimmune.

What topics will Altimmune (ALT) likely cover during the March 2026 fireside chats?

The company will discuss corporate updates and clinical progress, including pemvidutide development for liver diseases, during the fireside chats. According to the company, management will be available to address investor questions about development and strategy.